Medical Marijuana Market, By Types (Migraine, Arthritis, Cancer, Chronic Pain, and Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027
June 1, 2021
AnalystView Market Insights
247
pdf
Medical Marijuana Market, By Types (Migraine, Arthritis, Cancer, Chronic Pain, and Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027
Abstract REPORT HIGHLIGHT The medical marijuana market is valued USD 12.48 billion by 2016 with growth rate of 18.3%. According to the National Institute on Drug Abuse (NIDA), Marijuana (also referred as cannabis) is the dried leaves of female flowers of hemp plant which contain psychoactive properties. Delta- 9- tetrahydrocannabinol (Delta-9-THC) is the important psychoactive ingredient, the most abundant cannabinoid presents in marijuana. The movement to accept cannabis as a medicine is propel by multiple factors, including inadequate relief of current available treatment approaches for number of chronic disease conditions such as Crohn’s disease, multiple Sclerosis, cancer, Alzheimer’s disease, and chronic pain. Such conditions are frequently cited by the proponents of marijuana i.e. cannabis for medical use. The market for medical marijuana is primarily driven by the growing application of marijuana in mentioned medical conditions. Furthermore, large number of companies are increasingly investing in this market to capture significant revenue share. For example, Australia based MMJ PhytoTech Limited is considered to be the pioneer in the development of medical cannabis for international market, under regulated medical cannabis laws. The company is the first medical grade cannabis (MGC) company to list on the ASX. PhytoTech is primarily focused on the research and development activities on MGC therapeutics to be used in various medical applications. The company is aimed to become a leader in commercialization of cannabinoids based therapeutic products. Such initiatives would in turn help this market to establish healthy platform, hence drives the market growth. However, low penetration of marijuana for medical application in some developed as well as developing countries hamper the market growth. The market is categorized as Migraine, Arthritis, Cancer, Chronic Pain, and Others. Chronic pain segment achieved largest share of the total medical marijuana market, captured 35.26% share of the market. The use of pain medication is rapidly increasing, imposing a major burden on the healthcare system. The use of medical marijuana is reported to significantly alleviate pain symptoms. Its application in cancer and arthritis is also considered to be growing in near future due to advancements and increasing awareness among patient population. Regionally, developed countries of North America and Europe is the big market for medical marijuana. In Europe, medical cannabis is imported from Holland to the European countries such as Czech Republic, Croatia, Switzerland, Italy, Netherland, and others. Increasing number of prescriptions for the cannabis for various medical indication have surged the demand for medical marijuana in developed regions which will drive the market growth. For example, according to the Marijuana Business Fact Book (2014), more than 730,000 patients have received medical recommendation to use cannabis for different medical indication. Similarly, Health Canada, official forecast projected that medical cannabis patients will grow to 1.2% of the total Canadian population in next 10 years. This industry is predicated to grow at 25% to 28% (i.e. more than 400,000 patients) patient growth by 2024. Huge demand coupled with necessity to include cannabis for medical application will support the market growth. Owing to its huge benefits in medical application, the market is predicted to grow at slow but steady growth rate in developing regions. Government of some developing regions are considering marijuana as a potential economic opportunity. For example, Agriculture Minister of the Israeli government is researching to develop best ways to grow cannabis. The Health Ministry, having its own medical cannabis department is planning to extend the various licenses to support cannabis industry in the country. Such types of initiatives would in turn support the market growth to great extent during the forecast period. Companies such as Cannabis Sativa, Cara Therapeutics, Lexaria Corp, United Cannabis Corporation, CannaGrow Holdings Inc., International Consolidated Companies, Inc. and others are present in this market. These companies are investing huge amount of their revenue share on research and development activities to develop novel marijuana based therapeutics for medical applications. The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment. The years considered for the study are: Historical Year – 2016 to 2019 Base Year – 2020 Estimated Year – 2021 Projected Year – 2021-2026 TARGET AUDIENCE Traders, Distributors, And Suppliers Manufacturers Hospitals Government and Regional Agencies and Research Organizations Consultants Distributors SCOPE OF THE REPORT The scope of this report covers the market by its major segments, which include as follows: MARKET, BY TYPES Migraine Arthritis Cancer Chronic Pain Others MARKET, BY REGION North America Europe Asia Pacific Rest of the World MARKET, BY COUNTRY Further Breakdown of The North America Market U.S. Canada Further Breakdown of The Europe Market Germany France Finland Romania Italy Rest of Europe Further Breakdown of The APAC Market India China Rest of APAC Further Breakdown of The Rest of the World Market Middle East and Africa Latin America
Content TABLE OF CONTENTS MEDICAL MARIJUANA MARKET OVERVIEW Study Scope Base Year Assumption and Methodology EXECUTIVE SUMMARY Key Market Facts Geographical Scenario Companies in the Market MEDICAL MARIJUANA KEY MARKET TRENDS Market Drivers Impact Analysis of Market Drivers Market Restraints Impact Analysis of Market Restraints Market Opportunities Market Future Trends MEDICAL MARIJUANA INDUSTRY STUDY Regulatory Framework Analysis Pipeline Analysis Value Chain Analysis MEDICAL MARIJUANA MARKET LANDSCAPE Market Share Analysis Key Innovators MEDICAL MARIJUANA MARKET – BY TYPES: Overview Migraine Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Arthritis Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Cancer Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Chronic Pain Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Others Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) MEDICAL MARIJUANA MARKET– BY GEOGRAPHY Introduction North America Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) U.S. Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Canada Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Europe Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) France Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Germany Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Finland Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Romania Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Italy Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Rest of Europe Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Asia Pacific (APAC) Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) China Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) India Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Rest of APAC Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Rest of the World Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Latin America Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Middle East and Africa Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) KEY VENDOR ANALYSIS Cannabis Sativa Company Overview Product Benchmarking SWOT Analysis Key Developments Cara Therapeutics Company Overview Product Benchmarking SWOT Analysis Key Developments Lexaria Corp Company Overview Product Benchmarking SWOT Analysis Key Developments United Cannabis Corporation Company Overview Product Benchmarking SWOT Analysis Key Developments CannaGrow Holdings Inc. Company Overview Product Benchmarking SWOT Analysis Key Developments International Consolidated Companies, Inc. Company Overview Product Benchmarking SWOT Analysis Key Developments 360 DEGREE ANALYSTVIEW APPENDIX Research Methodology Abbreviations Disclaimer Contact Us SCOPE AND OBJECTIVES The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends. The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the market. The scope of this report covers the market by its major segments, which include the source, disease end user industry, and the major geographic regions. KEY BENEFITS OF THE REPORT: Understanding of the strategies that are being adopted by the key players in this market to stay competitive Extensive analysis of the key players dominating the competitive landscape of this market In-depth analysis of the key factors are propelling the growth of the global market Detailed analysis of the geographic region that will witness the strongest growth Granular analysis of the current market scenario and the expected market grow
REPORT HIGHLIGHT The medical marijuana market is valued USD 12.48 billion by 2016 with growth rate of 18.3%. According to the National Institute on Drug Abuse (NIDA), Marijuana (also referred as cannabis) is the dried leaves of female flowers of hemp plant which contain psychoactive properties. Delta- 9- tetrahydrocannabinol (Delta-9-THC) is the important psychoactive ingredient, the most abundant cannabinoid presents in marijuana. The movement to accept cannabis as a medicine is propel by multiple factors, including inadequate relief of current available treatment approaches for number of chronic disease conditions such as Crohn’s disease, multiple Sclerosis, cancer, Alzheimer’s disease, and chronic pain. Such conditions are frequently cited by the proponents of marijuana i.e. cannabis for medical use. The market for medical marijuana is primarily driven by the growing application of marijuana in mentioned medical conditions. Furthermore, large number of companies are increasingly investing in this market to capture significant revenue share. For example, Australia based MMJ PhytoTech Limited is considered to be the pioneer in the development of medical cannabis for international market, under regulated medical cannabis laws. The company is the first medical grade cannabis (MGC) company to list on the ASX. PhytoTech is primarily focused on the research and development activities on MGC therapeutics to be used in various medical applications. The company is aimed to become a leader in commercialization of cannabinoids based therapeutic products. Such initiatives would in turn help this market to establish healthy platform, hence drives the market growth. However, low penetration of marijuana for medical application in some developed as well as developing countries hamper the market growth. The market is categorized as Migraine, Arthritis, Cancer, Chronic Pain, and Others. Chronic pain segment achieved largest share of the total medical marijuana market, captured 35.26% share of the market. The use of pain medication is rapidly increasing, imposing a major burden on the healthcare system. The use of medical marijuana is reported to significantly alleviate pain symptoms. Its application in cancer and arthritis is also considered to be growing in near future due to advancements and increasing awareness among patient population. Regionally, developed countries of North America and Europe is the big market for medical marijuana. In Europe, medical cannabis is imported from Holland to the European countries such as Czech Republic, Croatia, Switzerland, Italy, Netherland, and others. Increasing number of prescriptions for the cannabis for various medical indication have surged the demand for medical marijuana in developed regions which will drive the market growth. For example, according to the Marijuana Business Fact Book (2014), more than 730,000 patients have received medical recommendation to use cannabis for different medical indication. Similarly, Health Canada, official forecast projected that medical cannabis patients will grow to 1.2% of the total Canadian population in next 10 years. This industry is predicated to grow at 25% to 28% (i.e. more than 400,000 patients) patient growth by 2024. Huge demand coupled with necessity to include cannabis for medical application will support the market growth. Owing to its huge benefits in medical application, the market is predicted to grow at slow but steady growth rate in developing regions. Government of some developing regions are considering marijuana as a potential economic opportunity. For example, Agriculture Minister of the Israeli government is researching to develop best ways to grow cannabis. The Health Ministry, having its own medical cannabis department is planning to extend the various licenses to support cannabis industry in the country. Such types of initiatives would in turn support the market growth to great extent during the forecast period. Companies such as Cannabis Sativa, Cara Therapeutics, Lexaria Corp, United Cannabis Corporation, CannaGrow Holdings Inc., International Consolidated Companies, Inc. and others are present in this market. These companies are investing huge amount of their revenue share on research and development activities to develop novel marijuana based therapeutics for medical applications. The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment. The years considered for the study are: Historical Year – 2016 to 2019 Base Year – 2020 Estimated Year – 2021 Projected Year – 2021-2026 TARGET AUDIENCE Traders, Distributors, And Suppliers Manufacturers Hospitals Government and Regional Agencies and Research Organizations Consultants Distributors SCOPE OF THE REPORT The scope of this report covers the market by its major segments, which include as follows: MARKET, BY TYPES Migraine Arthritis Cancer Chronic Pain Others MARKET, BY REGION North America Europe Asia Pacific Rest of the World MARKET, BY COUNTRY Further Breakdown of The North America Market U.S. Canada Further Breakdown of The Europe Market Germany France Finland Romania Italy Rest of Europe Further Breakdown of The APAC Market India China Rest of APAC Further Breakdown of The Rest of the World Market Middle East and Africa Latin America
TABLE OF CONTENTS MEDICAL MARIJUANA MARKET OVERVIEW Study Scope Base Year Assumption and Methodology EXECUTIVE SUMMARY Key Market Facts Geographical Scenario Companies in the Market MEDICAL MARIJUANA KEY MARKET TRENDS Market Drivers Impact Analysis of Market Drivers Market Restraints Impact Analysis of Market Restraints Market Opportunities Market Future Trends MEDICAL MARIJUANA INDUSTRY STUDY Regulatory Framework Analysis Pipeline Analysis Value Chain Analysis MEDICAL MARIJUANA MARKET LANDSCAPE Market Share Analysis Key Innovators MEDICAL MARIJUANA MARKET – BY TYPES: Overview Migraine Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Arthritis Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Cancer Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Chronic Pain Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Others Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) MEDICAL MARIJUANA MARKET– BY GEOGRAPHY Introduction North America Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) U.S. Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Canada Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Europe Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) France Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Germany Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Finland Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Romania Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Italy Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Rest of Europe Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Asia Pacific (APAC) Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) China Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) India Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Rest of APAC Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Rest of the World Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Latin America Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) Middle East and Africa Overview Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million) KEY VENDOR ANALYSIS Cannabis Sativa Company Overview Product Benchmarking SWOT Analysis Key Developments Cara Therapeutics Company Overview Product Benchmarking SWOT Analysis Key Developments Lexaria Corp Company Overview Product Benchmarking SWOT Analysis Key Developments United Cannabis Corporation Company Overview Product Benchmarking SWOT Analysis Key Developments CannaGrow Holdings Inc. Company Overview Product Benchmarking SWOT Analysis Key Developments International Consolidated Companies, Inc. Company Overview Product Benchmarking SWOT Analysis Key Developments 360 DEGREE ANALYSTVIEW APPENDIX Research Methodology Abbreviations Disclaimer Contact Us SCOPE AND OBJECTIVES The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends. The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the market. The scope of this report covers the market by its major segments, which include the source, disease end user industry, and the major geographic regions. KEY BENEFITS OF THE REPORT: Understanding of the strategies that are being adopted by the key players in this market to stay competitive Extensive analysis of the key players dominating the competitive landscape of this market In-depth analysis of the key factors are propelling the growth of the global market Detailed analysis of the geographic region that will witness the strongest growth Granular analysis of the current market scenario and the expected market grow